Thu.May 15, 2025

article thumbnail

Meet the Startup Using Dogs to Sniff Out Cancer

MedCity News

Israeli cancer diagnostics startup SpoititEarly launched in the U.S. It is developing a test that uses AI and trained canines to analyze patients breath samples, with the goal of detecting cancer at its earliest stages. The company plans to begin selling the at-home test to U.S. consumers next year. The post Meet the Startup Using Dogs to Sniff Out Cancer appeared first on MedCity News.

Training 290
article thumbnail

How to Identify & Cultivate the Essential Qualities of a Good Salesperson

Sales Talent

Hiring the right salesperson can make all the difference in your sales team’s success. Whether you’re a business owner aiming to build a high-performing sales team or a sales professional striving to reach peak performance, understanding the qualities of a good salesperson is vital. The best salespeople don’t simply sell; they build trust, solve problems, and drive growth.

Sales 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Imagine Reshaping The Surgical Landscape With Autonomous Surgery

MedCity News

To prepare for an autonomous surgical future, medtech leaders should explore the practical implications of potential scenarios, and structure investment accordingly. The key is to develop a living roadmap that drives decisions on a day-by-day basis, drawing on macro- and micro-trends. The post Imagine Reshaping The Surgical Landscape With Autonomous Surgery appeared first on MedCity News.

article thumbnail

AviadoBio opens UK trial for FTD gene therapy

PharmaTimes

Aspire-FTD study aims to stop disease progression with one-time treatment

105
105
article thumbnail

State of AI in Sales & Marketing 2025

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

article thumbnail

Everything You Need to Know About Who Accredits Health Plans for Mental Health Parity Compliance

MedCity News

[Sponsored] Who accredits health plans for mental health parity compliance? Learn about the only organization that offers this program to ensure your members get equitable care. The post Everything You Need to Know About Who Accredits Health Plans for Mental Health Parity Compliance appeared first on MedCity News.

More Trending

article thumbnail

Medbridge Announces New AI-Powered Motion-Capture Capabilities for MSK

MedCity News

With Medbridge’s new motion capture capabilities, patients can get more accurate feedback on therapeutic exercises while using their mobile phone or computers camera. The post Medbridge Announces New AI-Powered Motion-Capture Capabilities for MSK appeared first on MedCity News.

Patients 179
article thumbnail

A new CFO tasked with taking ‘scrappy’ Editas from last year’s layoffs into new gene editing territory

PharmaVoice

Amy Parison, who stepped into the lead financial role at the company in March, is managing Editas Medicine’s transition to a new gene editing platform while recovering from a major overhaul.

Medicine 173
article thumbnail

AbbVie’s Solid Tumor Strategy Gets a Win With Accelerated FDA Approval in Lung Cancer

MedCity News

Emrelis, an antibody drug conjugate developed by AbbVie, is now FDA approved for patients whose non-small cell lung cancer overexpresses the protein c-Met. The pharma company said this ADC is its first internally developed solid tumor medicine as well as its first solid tumor FDA approval in lung cancer. The post AbbVies Solid Tumor Strategy Gets a Win With Accelerated FDA Approval in Lung Cancer appeared first on MedCity News.

FDA 165
article thumbnail

Sanofi pledges a $20 billion investment programme in the US

pharmaphorum

Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in the US

article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

Patient-Centred Marketing: Shifting Focus from Products to People

eMediWrite

In the evolving world of healthcare, one trend is reshaping how pharmaceutical brands engage the market: the shift from product-centred to patient-centred marketing. Gone are the days when success was defined solely by product efficacy or sales numbers. Today, the true differentiator is how well we understand, empathise with, and support the real people behind every prescription.

article thumbnail

Do White Papers Still Work in Pharma Marketing?

Pharma Marketing Network

In a world of podcasts , reels, and AI-written content, its fair to ask: are white papers still pulling their weight in pharma marketing? For teams navigating omnichannel campaigns, strict MLR approvals, and buyer fatigue, the answer isn’t just “yes”it’s if done right, they work better than ever. Once the domain of technical audiences and B2B legacy brands, white papers have evolved.

article thumbnail

Kaerus gains FDA designations for Fragile X syndrome treatment

Pharmaceutical Technology

Kaerus Bioscience has received US Food and Drug Administrations (FDA) designations for KER-0193 to treat Fragile X syndrome (FXS).

article thumbnail

Takeda investigational drug shows efficacy in narcolepsy

European Pharmaceutical Review

New Phase IIb trial data has shown promising potential for Takeda’s oral orexin receptor 2 (OX2R)-selective agonist in narcolepsy type 1 (NT1). The findings, published in the New England Journal of Medicine , show that oveporexton (TAK-861) significantly improved disease severity, and enabled participants to attain levels of wakefulness of nearly normal ranges.

article thumbnail

The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

article thumbnail

AbbVie expands siRNA push with $335m ADARx deal

Pharmaceutical Technology

This marks AbbVies second major siRNA deal following its $1.4bn acquisition of Aliada Therapeutics in 2024.

52
article thumbnail

Merck KGaA Becomes Strategic Partner in Peregrine Ventures’ Incentive Incubator

PharmaTech

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields.

article thumbnail

FDA Approves Merck’s Welireg for Advanced, Unresectable, or Metastatic Pheochromocytoma, Paraganglioma

PharmExec

Welireg marks the first FDA-approved non-surgical treatment option for locally advanced, unresectable, or metastatic pheochromocytoma or paraganglioma in patients over 12 years of age.

FDA 52
article thumbnail

Engineering the future: how robotics and automation are transforming pharmaceutical logistics

Pharmaceutical Technology

From predictive analytics to robotic warehousing, automation is unlocking new efficiencies in pharma logistics.

article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

ISPE Announces Six 2025 FOYA Category Winners

PharmaTech

Six winners and two honorable mentions were revealed at ISPEs Europe Annual Conference in London.

59
article thumbnail

FDA awards BioCryst’s Orladeyo NDA for paediatric HAE

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has accepted BioCryst Pharmaceuticals new drug application (NDA) for Orladeyo.

article thumbnail

Simulated Pre-Launch Market Evaluation in the Modern Pharmaceutical Industry

PharmExec

The window of opportunity for launch is short and unforgiving, and the success depends on flawless execution of launch activity across countries and functions.

article thumbnail

Oligonucleotides: The Scottish research hub accelerating production scale up

Pharmaceutical Technology

A new specialist manufacturing facility in Scotland could soon provide solutions to scaling challenges for vital oligonucleotide therapies.

article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

DeepL Announces HIPPA-Compliant AI

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Introducing the Pharmaceutical Technology Excellence Awards 2025

Pharmaceutical Technology

The 2025 Pharmaceutical Technology Excellence Awards are now open for submissions, and you can download our Research Guide for more details.

article thumbnail

NAMI Responds to Potential Cuts to Medicaid

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Millennial Healthcare Marketing: Winning the Digital-Native Generation

Healthcare Success

Millennials expect digital healthcare to feel like the apps they use every day: frictionless, fast, accessible, and on their terms. Is your marketing strategy built to meet them there or are you relying on an outdated marketing plan that doesnt resonate? In this blog post, I share seven proven strategies to help you connect, compete, and win over this digital-native generation.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Podcast: AI and Supervised Machine Learning in Clinical Trials – Ep1

Pharmaceutical Technology

AI and supervised machine learning have considerable benefits for clinical trials.

52
article thumbnail

AbbVie bags first approval for cancer ADC Emrelis

pharmaphorum

AbbVie has claimed its first global regulatory approval, from the FDA, for its C-met-targeting lung cancer ADC Emrelis

FDA 66
article thumbnail

Themes Among Rare Disease Repurposing Efforts

Pharmaceutical Commerce

A qualitative study aimed to strengthen systematic repurposing efforts within rare disease nonprofit organizations, while also providing a framework for data-driven drug repurposing.

59